Tumor necrosis factor superfamily in innate immunity and inflammation

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 4, 2015, Pages

  Šedý, John ^a   Bekiaris, Vasileios ^a   Ware, Carl F ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPESVIRIDAE; SIMPLEXVIRUS;

BTLA PROTEIN, HUMAN; CD160 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOTOXIN ALPHA BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM;

ANIMALS; ANTIGENS, CD; GPI-LINKED PROTEINS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHOCYTES; LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 84926500281     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016279     Document Type: Article

References (172)

1. Abecassis S, Giustiniani J, Meyer N, Schiavon V, Ortonne N, Campillo JA, Bagot M, Bensussan A. 2007. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: A possible role for CD160 in skin inflammation. J Invest Dermatol 127: 1161-1166.
2. Aebischer J, Moumen A, Sazdovitch V, Seilhean D, Meininger V, Raoul C. 2012. Elevated levels of IFN-g and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 19: 752-759, e745-756.
3. Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.
4. Baccala R, Witherden D, Gonzalez-Quintial R, Dummer W, Surh CD, Havran WL, Theofilopoulos AN. 2005. gd T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J Immunol 174: 4606-4612.
5. Banks TA, Rickert S, Benedict CA, Ma L, Ko M, Meier J, Ha W, Schneider K, Granger SW, Turovskaya O, et al. 2005. A lymphotoxin-IFN-b axis essential for lymphocyte survival revealed during cytomegalovirus infection. J Immunol 174: 7217-7225.
6. Barakonyi A, Rabot M, Marie-Cardine A, Aguerre-Girr M, Polgar B, Schiavon V, Bensussan A, Le Bouteiller P. 2004. Cutting edge: Engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol 173: 5349-5354.
7. Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM. 2010. Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity (Silver Spring) 18: 239-246.
8. Batista MD, Ho EL, Kuebler PJ, Milush JM, Lanier LL, Kallas EG, York VA, Chang D, Liao W, Unemori P, et al. 2013. Skewed distribution of natural killer cells in psoriasis skin lesions. Exp Dermatol 22: 64-66.
9. Bekiaris V, Gaspal F, McConnell FM, Kim MY, Withers DR, Sweet C, Anderson G, Lane PJ. 2009. NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism. Eur J Immunol 39: 2800-2808.
10. Bekiaris V, Šedý JR, Macauley MG, Rhode-Kurnow A, Ware CF. 2013a. The inhibitory receptor BTLA controls gd T cell homeostasis and inflammatory responses. Immunity 12: 1082-1094.
11. Bekiaris V, Šedý JR, Rossetti M, Spreafico R, Sharma S, Rhode-Kurnow A, Ware BC, Huang N, Macauley MG, Norris PS, et al. 2013b. Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-ab and are elevated in rheumatoid arthritis. J Immunol 191: 4611-4618.
12. Benedict C, Butrovich K, Lurain N, Corbeil J, Rooney I, Schenider P, Tschopp J, Ware C. 1999. Cutting Edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162: 6967-6970.
13. Benedict CA, De Trez C, Schneider K, Ha S, Patterson G, Ware CF. 2006. Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog 2: e16.
14. Benezech C, Mader E, Desanti G, Khan M, Nakamura K, White A, Ware CF, Anderson G, Caamano JH. 2012. Lymphotoxin-b receptor signaling through NF-kB2- RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity 37: 721-734.
15. Bernink J, Mjosberg J, Spits H. 2013. Th1- and Th2-like subsets of innate lymphoid cells. Immunol Rev 252: 133-138.
16. Bjordahl RL, Steidl C, Gascoyne RD, Ware CF. 2013. Lymphotoxin network pathways shape the tumor microenvironment. Curr Opin Immunol 25: 222-229.
17. Blanco-Kelly F, Alvarez-Lafuente R, Alcina A, Abad-Grau MM, de Las Heras V, Lucas M, de la Concha EG, Fernandez O, Arroyo R, Matesanz F, et al. 2011.Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition. Genes Immun 12: 145-148.
18. Boliar S, Murphy MK, Tran TC, Carnathan DG, Armstrong WS, Silvestri G, Derdeyn CA. 2012. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth. J Virol 86: 8031-8040.
19. Boos MD, Yokota Y, Eberl G, Kee BL. 2007. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 204: 1119-1130.
20. Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, Menasce LP, Radford JA, Illidge T. 2008. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 111: 4764-4770.
21. Caccamo N, Dieli F, Meraviglia S, Guggino G, Salerno A. 2010. Gd T cell modulation in anticancer treatment. Curr Cancer Drug Targets 10: 27-36.
22. Cai G, Freeman GJ. 2009. The CD160, BTLA, LIGHT/ HVEM pathway: A bidirectional switch regulating Tcell activation. Immunol Rev 229: 244-258.
23. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. 2008. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9: 176-185.
24. Cai Y, Shen X, Ding C, Qi C, Li K, Li X, Jala VR, Zhang HG, Wang T, Zheng J, et al. 2011. Pivotal role of dermal IL- 17-producing gd T cells in skin inflammation. Immunity 35: 596-610.
25. Cai G, Nie X, Li L, Hu L, Wu B, Lin J, Jiang C, Wang H, Wang X, Shen Q. 2013. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function. J Gastroenterol 48: 1362-1372.
26. Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E. 2009. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27: 1470-1476.
27. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL, Carroll MC, Rajewsky K. 2004. B cell receptor signal strength determines B cell fate. Nat Immunol 5: 317-327.
28. Celik S, Shankar V, Richter A, Hippe HJ, Akhavanpoor M, Bea F, Erbel C, Urban S, Blank N, Wambsganss N, et al. 2009. Proinflammatory and prothrombotic effects on human vascular endothelial cells of immune-cell-derived LIGHT. Eur J Med Res 14: 147-156.
29. Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, et al. 2005. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci 102: 13218-13223.
30. Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, Sanjo H, D’Souza C, Norris PS, Pfeffer K, Murphy KM, et al. 2009. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci 106: 6244-6249.
31. Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin RD, Moore R, Shah SP, et al. 2010. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70: 9166-9174.
32. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, Mackay CR. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173: 68-78.
33. Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H. 2009. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10: 66-74.
34. Cyster JG. 2003. Lymphoid organ development and cell migration. Immunol Rev 195: 5-14.
35. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxin- b receptor induces different patterns of gene expression via two NF-kB pathways. Immunity 17: 525-535.
36. Deppong C, Juehne TI, Hurchla M, Friend LD, Shah DD, Rose CM, Bricker TL, Shornick LP, Crouch EC, Murphy TL, et al. 2006. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol 176: 3909-3913.
37. De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, Ha SW, Fu YX, Murphy T, Murphy KM, et al. 2008. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol 180: 238-248.
38. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, Zhernakova A, Heap GA, Adany R, Aromaa A, et al. 2010. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
39. Endres R, Alimzhanov MB, Plitz T, Futterer A, Kosco-Vilbois MH, Nedospasov SA, Rajewsky K, Pfeffer K. 1999. Mature follicular dendritic cell networks depend on expression of lymphotoxin b receptor by radioresistant stromal cells and of lymphotoxin b and tumor necrosis factor by B cells. J Exp Med 189: 159-168.
40. Farren TW, Giustiniani J, Liu FT, Tsitsikas DA, Macey MG, Cavenagh JD, Oakervee HE, Taussig D, Newland AC, Calaminici M, et al. 2011. Differential and tumor-specific expression of CD160 in B-cell malignancies. Blood 118: 2174-2183.
41. Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Anasetti C, Weisdorf D, Miller JS. 2012a. Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol 189: 5082-5088.
42. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Verges S, Lanier LL, Weisdorf D, Miller JS. 2012b. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119: 2665-2674.
43. Fu Z, Li D, Jiang W, Wang L, Zhang J, Xu F, Pang D. 2009. Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinesewomen of Heilongjiang Province. Breast Cancer Res Treat 120: 195-202.
44. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M. 2013. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-g-producing cells. Immunity 38: 769-781.
45. Gantsev SK, Umezawa K, Islamgulov DV, Khusnutdinova EK, Ishmuratova RS, Frolova VY, Kzyrgalin SR. 2013. The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer. Biomed Pharmacother 67: 363-366.
46. Garrido VT, Proenca-Ferreira R, Dominical VM, Traina F, Bezerra MA, de Mello MR, Colella MP, Araujo AS, Saad ST, Costa FF, et al. 2012. Elevated plasma levels and platelet- associated expression of the pro-thrombotic and proinflammatory protein, TNFSF14 (LIGHT), in sickle cell disease. Br J Haematol 158: 788-797.
47. Gascoyne DM, Long E, Veiga-Fernandes H, de Boer J, Williams O, Seddon B, Coles M, Kioussis D, Brady HJ. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 10: 1118-1124.
48. Gavrieli M, Murphy KM. 2006. Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA. Biochem Biophys Res Commun 345: 1440-1445.
49. Gertner-Dardenne J, Fauriat C, Orlanducci F, Thibult ML, Pastor S, Fitzgibbon J, Bouabdallah R, Xerri L, Olive D. 2013. The co-receptor BTLA negatively regulates human Vg9Vd2 T-cell proliferation: A potential way of immune escape for lymphoma cells. Blood 122: 922-931.
50. Giustiniani J, Alaoui SS, Marie-Cardine A, Bernard J, Olive D, Bos C, Razafindratsita A, Petropoulou A, de Latour RP, Le Bouteiller P, et al. 2012. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria. Curr Mol Med 12: 188-198.
51. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, Lindsten T, Reiner SL. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67.
52. Guo P, Hirano M, Herrin BR, Li J, Yu C, Sadlonova A, Cooper MD. 2009. Dual nature of the adaptive immune system in lampreys. Nature 459: 796-801.
53. Harly C, Guillaume Y, Nedellec S, Peigne CM, Monkkonen H, Monkkonen J, Li J, Kuball J, Adams EJ, Netzer S, et al. 2012. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gd T-cell subset. Blood 120: 2269-2279.
54. Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, et al. 2013. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem 288: 8679-8690.
55. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. 2002. Small anti-viral compounds activate immune cells via the TLR7MyD88-dependent signaling pathway. Nat Immunol 3: 196-200.
56. Herraez DL, Martinez-Bueno M, Riba L, de la Torre IG, Sacnun M, Goni M, Berbotto GA, Paira S, Musuruana JL, Graf CE, et al. 2013. Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region. Arthritis Rheum 65: 1457-1467.
57. Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, Trilling M, Klingel K, Sauter M, Kandolf R, Gailus N, et al. 2012. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol 13: 51-57.
58. Johnson DJ, Pao LI, Dhanji S, Murakami K, Ohashi PS, Neel BG. 2013. Shp1 regulates T cell homeostasis by limiting IL-4 signals. J Exp Med 210: 1419-1431.
59. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
60. Jung HW, La SJ, Kim JY, Heo SK, Wang S, Kim KK, Lee KM, Cho HR, Lee HW, Kwon B, et al. 2003. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp Mol Med 35: 501-508.
61. Junt T, Scandella E, Ludewig B. 2008. Form follows function: Lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 8: 764-775.
62. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. 2005. Intrinsic lymphotoxin-b receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 22: 439-450.
63. Kalyan S, Kabelitz D. 2013. Defining the nature of human gd T cells: A biographical sketch of the highly empathetic. Cell Mol Immunol 10: 21-29.
64. Kamizono S, Duncan GS, Seidel MG, Morimoto A, Hamada K, Grosveld G, Akashi K, Lind EF, Haight JP, Ohashi PS, et al. 2009. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J Exp Med 206: 2977-2986.
65. Kaye J. 2008. CD160 and BTLA: LIGHTs out for CD4+ T cells. Nat Immunol 9: 122-124.
66. Khanna KM, Lefrancois L. 2012. B cells, not just for antibody anymore. Immunity 36: 315-317.
67. Kim MY, Gaspal FM, Wiggett HE, McConnell FM, Gulbranson-Judge A, Raykundalia C, Walker LS, Goodall MD, Lane PJ. 2003. CD4+CD3- accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18: 643-654.
68. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. 2006a. Ube1L and protein ISGylation are not essential for a/b interferon signaling. Mol Cell Biol 26: 472-479.
69. Kim MY, Toellner KM, White A, McConnell FM, Gaspal FM, Parnell SM, Jenkinson E, Anderson G, Lane PJ. 2006b. Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J Immunol 177: 3074-3081.
70. Kim JH, Luo JK, Zhang DE. 2008. The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression. J Immunol 181: 6467-6472.
71. Kobayashi Y, Iwata A, Suzuki K, Suto A, Kawashima S, Saito Y, Owada T, Kobayashi M, Watanabe N, Nakajima H. 2013. B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells. Proc Natl Acad Sci 110: 5121-5126.
72. Kojima R, Kajikawa M, Shiroishi M, Kuroki K, Maenaka K. 2011. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. J Mol Biol 413: 762-772.
73. Kong M, Kim Y, Lee C. 2008. Promoter sequence variants of LIGHT are associated with female vascular dementia. J Biomed Sci 15: 545-552.
74. Kotani H, Masuda K, Tamagawa-Mineoka R, Nomiyama T, Soga F, Nin M, Asai J, Kishimoto S, Katoh N. 2012. Increased plasma LIGHT levels in patients with atopic dermatitis. Clin Exp Immunol 168: 318-324.
75. Kraal G, Mebius R. 2006. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol 250: 175-215.
76. Kruglov AA, Grivennikov SI, Kuprash DV, Winsauer C, Prepens S, Seleznik GM, Eberl G, Littman DR, Heikenwalder M, Tumanov AV, et al. 2013. Nonredundant function of soluble LT-a3 produced by innate lymphoid cells in intestinal homeostasis. Science 342: 1243-1246.
77. Lanier LL. 2008. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8: 259-268.
78. Larsson M, Shankar EM, Che KF, Saeidi A, Ellegard R, Barathan M, Velu V, Kamarulzaman A. 2013. Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology 10: 31.
79. Launay E, Pangault C, Bertrand P, Jardin F, Lamy T, Tilly H, Tarte K, Bastard C, Fest T. 2012. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia 26: 559-562.
80. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J, et al. 2002. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci 99: 16963-16968.
81. Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, Berrebi A, Aguerre-Girr M, Bensussan A, Jabrane-Ferrat N. 2011. CD160: A unique activating NK cell receptor. Immunol Lett 138: 93-96.
82. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE. 2001. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21: 2004-2010.
83. Lepenies B, Pfeffer K, Hurchla MA, Murphy TL, Murphy KM, Oetzel J, Fleischer B, Jacobs T. 2007. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J Immunol 179: 4093-4100.
84. Lin SC, Kuo CC, Chan CH. 2006. Association of a BTLA gene polymorphismwith the risk of rheumatoid arthritis. J Biomed Sci 13: 853-860.
85. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, Cyster JG, Luther SA. 2007. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 8: 1255-1265.
86. Liu GZ, Fang LB, Hjelmstrom P, Gao XG. 2008. Enhanced plasma levels of LIGHT in patients with acute atherothrombotic stroke. Acta Neurol Scand 118: 256-259.
87. Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104: 487-501.
88. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, et al. 2012. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci 109: 3879-3884.
89. Lopez RD. 2013. Inhibiting inhibitory pathways in human gd T cells. Blood 122: 857-858.
90. Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, et al. 2011. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci 108: 14725-14732.
91. Maeda M, Carpenito C, Russell RC, Dasanjh J, Veinotte LL, Ohta H, Yamamura T, Tan R, Takei F. 2005. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol 175: 4426-4432.
92. Maiza H, Leca G, Mansur IG, Schiavon V, Boumsell L, Bensussan A. 1993. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 178: 1121-1126.
93. Marrack P, Kappler J, Mitchell T. 1999. Type I interferons keep activated T cells alive. J Exp Med 189: 521-530.
94. Martin-Guerrero I, Salaverria I, Burkhardt B, Szczepanowski M, Baudis M, Bens S, de Leval L, Garcia-Orad A, Horn H, Lisfeld J, et al. 2013. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. Haematologica 98: 1237-1241.
95. Mauldin IS, Tung KS, Lorenz UM. 2012. The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood 119: 4419-4429.
96. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin a are ligands for herpesvirus entry mediator. Immunity 8: 21-30.
97. Mebius RE, Rennert P, Weissman IL. 1997. Developinglymph nodes collect CD4+CD3- LT-b+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7: 493-504.
98. Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R, Acha-Orbea H, Finke D. 2007. Ectopic lymphoid- organ development occurs through interleukin 7- mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 26: 643-654.
99. M’Hidi H, Thibult ML, Chetaille B, Rey F, Bouadallah R, Nicollas R, Olive D, Xerri L. 2009. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Am J Clin Pathol 132: 589-596.
100. Mortarini R, Scarito A, Nonaka D, Zanon M, Bersani I, Montaldi E, Pennacchioli E, Patuzzo R, Santinami M, Anichini A. 2005. Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles. Cancer Res 65: 3428-3436.
101. Moseman EA, Iannacone M, Bosurgi L, Tonti E, Chevrier N, Tumanov A, Fu YX, Hacohen N, von Andrian UH. 2012. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 36: 415-426.
102. Muntasell A, Vilches C, Angulo A, Lopez-Botet M. 2013. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction. Eur J Immunol 43: 1133-1141.
103. Murphy TL, Murphy KM. 2010. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28: 389-411.
104. Murphy M, Walter BN, Pike-Nobile L, Fanger NA, Guyre PM, Browning JL, Ware CF, Epstein LB. 1998. Expression of the lymphotoxin b-receptor on follicular stromal cells in human lymphoid tissue. Cell Death Differ 5: 497-505.
105. Murphy KM, Nelson CA, Šedé JR. 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 6: 671-681.
106. Nikolova M, Marie-Cardine A, Boumsell L, Bensussan A. 2002. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int Immunol 14: 445-451.
107. Nolte MA, Belien JA, Schadee-Eestermans I, Jansen W, Unger WW, van Rooijen N, Kraal G, Mebius RE. 2003. A conduit system distributes chemokines and small bloodborne molecules through the splenic white pulp. J Exp Med 198: 505-512.
108. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, Wang YH, Watowich SS, Jetten AM, Tian Q, et al. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.
109. Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T, Akahane S, Homma Y, Nishizawa O. 2010. CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis. J Urol 183: 1206-1212.
110. Oki M, Watanabe N, Owada T, Oya Y, Ikeda K, Saito Y, Matsumura R, Seto Y, Iwamoto I, Nakajima H. 2011. A functional polymorphism in B and T lymphocyte attenuator is associated with susceptibility to rheumatoid arthritis. Clin Dev Immunol 2011: 305-656.
111. Pangault C, Ame-Thomas P, Ruminy P, Rossille D, Caron G, Baia M, De Vos J, Roussel M, Monvoisin C, Lamy T, et al. 2010. Follicular lymphoma cell niche: Identification of a preeminent IL-4-dependent TFH-B cell axis. Leukemia 24: 2080-2089.
112. Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, Becher B. 2012. Rorgt+ innate lymphocytes and gd T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122: 2252-2256.
113. Pao LI, Badour K, Siminovitch KA, Neel BG. 2007. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu Rev Immunol 25: 473-523.
114. Patel F, Marusina AI, Duong C, Adamopoulos IE, Maverakis E. 2013. NKG2C, HLA-E and their association with psoriasis. Exp Dermatol 22: 797-799.
115. Perdigones N, Vigo AG, Lamas JR, Martinez A, Balsa A, Pascual-Salcedo D, de la Concha EG, Fernandez-Gutierrez B, Urcelay E. 2010. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. Arthritis Rheum 62: 705-710.
116. Peretz Y, He Z, Shi Y, Yassine-Diab B, Goulet JP, Bordi R, Filali-Mouhim A, Loubert JB, El-Far M, Dupuy FP, et al. 2012. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 8: e1002840.
117. Poole E, King CA, Sinclair JH, Alcami A. 2006. The UL144 gene product of human cytomegalovirus activates NF-kB via a TRAF6-dependent mechanism. EMBO J 25: 4390-4399.
118. Powolny-Budnicka I, Riemann M, Tanzer S, Schmid RM, Hehlgans T, Weih F. 2011. RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin- dependent interleukin-17 production in gd T cells. Immunity 34: 364-374.
119. Rabot M, Bensussan A, Le Bouteiller P. 2006. Engagement of the CD160 activating NK cell receptor leads to its association with CD2 in circulating human NK cells. Transpl Immunol 17: 36-38.
120. Rabot M, El Costa H, Polgar B, Marie-Cardine A, Aguerre-Girr M, Barakonyi A, Valitutti S, Bensussan A, Le Bouteiller P. 2007. CD160-activating NK cell effector functions depend on the phosphatidylinositol-3-kinase recruitment. Int Immunol 19: 401-409.
121. Rakesh K, Agrawal DK. 2005. Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 70: 649-657.
122. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, et al. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40: 1216-1223.
123. Ribot JC, Silva-Santos B. 2013. Differentiation and activation of gd T Lymphocytes: Focus on CD27 and CD28 costimulatory receptors. Adv Exp Med Biol 785: 95-105.
124. Ribot JC, de Barros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, et al. 2009. CD27 is a thymic determinant of the balance between interferon-g- and interleukin-17-producing gd T cell subsets. Nat Immunol 10: 427-436.
125. Sanjo H, Zajonc DM, Braden R, Norris PS, Ware CF. 2010. Allosteric regulation of the ubiquitin: NIK and ubiquitin: TRAF3 E3 ligases by the lymphotoxin-b receptor. J Biol Chem 285: 17148-17155.
126. Satpathy AT, Briseno CG, Lee JS, Ng D, Manieri NA, Kc W, Wu X, Thomas SR, Lee WL, Turkoz M, et al. 2013. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol 14: 937-948.
127. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G. 2010. Lineage relationship analysis of RORgt+ innate lymphoid cells. Science 330: 665-669.
128. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, et al. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
129. Schneider K, Loewendorf A, De Trez C, Fulton J, Rhode A, Shumway H, Ha S, Patterson G, Pfeffer K, Nedospasov SA, et al. 2008. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3: 67-76.
130. Scholz H, Sandberg W, Damas JK, Smith C, Andreassen AK, Gullestad L, Froland SS, Yndestad A, Aukrust P, Halvorsen B. 2005. Enhanced plasma levels of LIGHT in unstable angina: Possible pathogenic role in foam cell formation and thrombosis. Circulation 112: 2121-2129.
131. Šedý JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, et al. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6: 90-98.
132. Šedý JR, Spear PG, Ware CF. 2008. Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8: 861-873.
133. Šedý JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, Lurain NS, Benedict CA, Ware CF. 2013. CD160 Activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J Immunol 15: 828-836.
134. Serriari NE, Gondois-Rey F, Guillaume Y, Remmerswaal EB, Pastor S, Messal N, Truneh A, Hirsch I, van Lier RA, Olive D. 2010. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J Immunol 185: 3140-3148.
135. Shang Y, Guo G, Cui Q, Li J, Ruan Z, Chen Y. 2012a. The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovium. Inflammation 35: 1102-1112.
136. Shang YJ, Cui QF, Li JL, Guo GN, Zhu WY. 2012b. Expression of the costimulatory molecule BTLA in synovial tissues from rheumatoid arthritis patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 28: 643-646.
137. Shui JW, Larange A, Kim G, Vela JL, Zahner S, Cheroutre H, Kronenberg M. 2012. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488: 222-225.
138. Silva-Santos B, Pennington DJ, Hayday AC. 2005. Lymphotoxin- mediated regulation of gd cell differentiation by ab T cell progenitors. Science 307: 925-928.
139. Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemcovicova I, Wang EC, Stanton RJ, Macauley M, Norris P, Willen L, et al. 2013. Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe 13: 324-335.
140. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, et al. 2013. Innate lymphoid cells-A proposal for uniform nomenclature. Nat Rev Immunol 13: 145-149.
141. Steinberg MW, Turovskaya O, Shaikh RB, Kim G, McCole DF, Pfeffer K, Murphy KM, Ware CF, Kronenberg M. 2008. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med 205: 1463-1476.
142. Summers de Luca L, Ng D, Gao Y, Wortzman ME, Watts TH, Gommerman JL. 2011. LT-bR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells. Proc Natl Acad Sci 108: 2046-2051.
143. Sun Y, Brown NK, Ruddy MJ, Miller ML, Lee Y, Wang Y, Murphy KM, Pfeffer K, Chen L, Kaye J, et al. 2009. B and T lymphocyte attenuator tempers early infection immunity. J Immunol 183: 1946-1951.
144. Sun X, Shibata K, Yamada H, Guo Y, Muta H, Podack ER, Yoshikai Y. 2013. CD30L/CD30 is critical for maintenance of IL-17A-producing gd T cells bearing Vg6 in mucosa-associated tissues in mice. Mucosal Immunol 6: 1191-1201.
145. Sutton CE, Mielke LA, Mills KH. 2012. IL-17-producing gd T cells and innate lymphoid cells. Eur J Immunol 42: 2221-2231.
146. Tao R, Wang L, Han R, Wang T, Ye Q, Honjo T, Murphy TL, Murphy KM, Hancock WW. 2005. Differential effects of B and T lymphocyte attenuator and programmed death- 1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol 175: 5774-5782.
147. Tiganis T, Bennett AM. 2007. Protein tyrosine phosphatase function: The substrate perspective. Biochem J 402: 1-15.
148. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P, Kusser K, Hopken UE, Lipp M, Niederreither K, et al. 2009. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol 10: 1193-1199.
149. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, et al. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845.
150. Van Vactor D, O’Reilly AM, Neel BG. 1998. Genetic analysis of protein tyrosine phosphatases. Curr Opin Genet Dev 8: 112-126.
151. Vendel AC, Calemine-Fenaux J, Izrael-Tomasevic A, Chauhan V, Arnott D, Eaton DL. 2009. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J Immunol 182: 1509-1517.
152. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
153. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Holscher C, et al. 2010. Regulated expression of nuclear receptor RORgt confers distinct functional fates to NK cell receptor- expressing RORgt+ innate lymphocytes. Immunity 33: 736-751.
154. Vondenhoff MF, Greuter M, Goverse G, Elewaut D, Dewint P, Ware CF, Hoorweg K, Kraal G, Mebius RE. 2009. LT-bR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen. J Immunol 182: 5439-5445.
155. Walczak H. 2011. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev 244: 9-28.
156. Walter A, Schafer M, Cecconi V, Matter C, Urosevic-Maiwald M, Belloni B, Schonewolf N, Dummer R, Bloch W, Werner S, et al. 2013. Aldara activates TLR7-independent immune defence. Nat Commun 4: 1560.
157. Wang Y, Koroleva EP, Kruglov AA, Kuprash DV, Nedospasov SA, Fu YX, Tumanov AV. 2010. Lymphotoxin b receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32: 403-413.
158. Ware CF. 2005. Network communications: Lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23: 787-819.
159. Ware CF, Benedict C. 2012. Innate B cells: Oxymoron or validated concept?. F1000Res 1: 8.
160. Ware CF, Sˇedy´ JR. 2011. TNF superfamily networks: Bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Curr Opin Immunol 23: 627-631.
161. Watanabe N, Nakajima H. 2012. Coinhibitory molecules in autoimmune diseases. Clin Dev Immunol 2012: 269756.
162. Watanabe N, Gavrieli M, Šedý JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4: 670-679.
163. Watchmaker PB, Lahl K, Lee M, Baumjohann D, Morton J, Kim SJ, Zeng R, Dent A, Ansel KM, Diamond B, et al. 2014. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nat Immunol 15: 98-108.
164. Wencker M, Turchinovich G, Di Marco Barros R, Deban L, Jandke A, Cope A, Hayday AC. 2014. Innate-like T cells straddle innate and adaptive immunity by altering antigen- receptor responsiveness. Nat Immunol 15: 80-87.
165. White A, Carragher D, Parnell S, Msaki A, Perkins N, Lane P, Jenkinson E, Anderson G, Caamano JH. 2007. Lymphotoxin a-dependent and -independent signals regulate stromal organiser cell homeostasis during lymph node organogenesis. Blood 15: 1950-1959.
166. Wiens GD, Glenney GW. 2011. Origin and evolution of TNF and TNF receptor superfamilies. Dev Comp Immunol 35: 1324-1335.
167. Wohn C, Ober-Blobaum JL, Haak S, Pantelyushin S, Cheong C, Zahner SP, Onderwater S, Kant M, Weighardt H, Holzmann B, et al. 2013. Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. ProcNatl Acad Sci 110: 10723-10728.
168. Wu TH, Zhen Y, Zeng C, Yi HF, Zhao Y. 2007. B and T lymphocyte attenuator interacts with CD3z and inhibits tyrosine phosphorylation of TCRz complex during T-cell activation. Immunol Cell Biol 85: 590-595.
169. Xu XS, Zhang Z, Gu LL, Wang FS. 2009. BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 25: 1158-1160.
170. Yoshida H, Naito A, Inoue J, Satoh M, Santee-Cooper SM, Ware CF, Togawa A, Nishikawa S, Nishikawa S. 2002. Different cytokines induce surface lymphotoxin-ab on IL-7 receptor-a cells that differentially engender lymph nodes and Peyer’s patches. Immunity 17: 823-833.
171. Zeng X, Chen H, Gupta R, Paz-Altschul O, Bowcock AM, Liao W. 2013. Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility. Exp Dermatol 22: 679-681.
172. Zhang Z, Xu X, Lu J, Zhang S, Gu L, Fu J, Jin L, Li H, Zhao M, Zhang J, et al. 2011. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation. J Infect Dis 203: 1668-1678.